SB 494 – Rhode Island

Status: In Process
Year Introduced: 2021
Link: http://webserver.rilin.state.ri.us/BillText/BillText21/SenateText21/S0494A.pdf

AN ACT RELATING TO INSURANCE: Requires drug companies disclose to office of the health insurance commissioner acquisition costs of drugs approved by FDA, if acquisition cost is at least $100 for 30 day supply and requires disclosure of rebates, price protection payments.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found